Literature DB >> 10795764

Prediction of short-term outcome for patients with active ulcerative colitis.

N Oshitani1, T Matsumoto, Y Jinno, Y Sawa, J Hara, S Nakamura, T Arakawa, A Kitano, T Kuroki.   

Abstract

We report results of a retrospective chart review to evaluate factors predicting short-term outcome of patients with ulcerative colitis treated by corticosteroids. Between January 1992 and December 1997, we treated 71 patients with ulcerative colitis (44 with severe and 27 with moderately severe disease). Forty-nine patients were treated by conventional prednisolone therapy and 22 patients by steroid pulse therapy. There were no differences in clinical or endoscopic improvement between the two treatments. Clinical examination showed that 41 patients entered remission, 17 patients improved, and 13 patients did not respond. Endoscopically, 26 patients entered remission, 30 patients improved, and 15 patients did not respond. Extent of disease, type of disease (first attack, relapsing, or chronic active type), and endoscopic findings were factors useful in predicting short-term outcome of medical treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795764     DOI: 10.1023/a:1005589428082

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

3.  Course of severe ulcerative colitis in northern India.

Authors:  R Gulati; K K Rawal; N Kumar; M Jain; A S Puri; A Govil; A K Sachdeva; A Chaudhary
Journal:  Trop Gastroenterol       Date:  1995 Jul-Sep

4.  Endoscopic decompression in "toxic megacolon".

Authors:  L Riedler; D Wohlgenannt; F Stoss; W Thaler; K W Schmid
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

5.  Endoscopic colonic decompression of toxic megacolon, placement of colonic tube, and steroid colonclysis.

Authors:  A V Banez; F Yamanishi; C A Crans
Journal:  Am J Gastroenterol       Date:  1987-07       Impact factor: 10.864

6.  Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation.

Authors:  J C Goligher; D C Hoffman; F T de Dombal
Journal:  Br Med J       Date:  1970-12-19

7.  The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.

Authors:  M B Richter; P Woo; G S Panayi; A Trull; A Unger; P Shepherd
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

8.  Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial.

Authors:  S Meyers; P K Lerer; E J Feuer; J W Johnson; H D Janowitz
Journal:  J Clin Gastroenterol       Date:  1987-02       Impact factor: 3.062

9.  The prognosis of inflammatory bowel disease.

Authors:  D J Sales; J B Kirsner
Journal:  Arch Intern Med       Date:  1983-02

10.  Intensive intravenous treatment of ulcerative colitis.

Authors:  G Järnerot; P Rolny; H Sandberg-Gertzén
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

View more
  4 in total

1.  Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors.

Authors:  Shigeki Bamba; Akira Andoh; Hirotsugu Imaeda; Hiromitsu Ban; Ayako Kobori; Yousuke Mochizuki; Makoto Shioya; Takashi Nishimura; Osamu Inatomi; Masaya Sasaki; Yasuharu Saitoh; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

2.  Outpatient treatment of moderately severe active ulcerative colitis with pulsed steroid therapy and conventional steroid therapy.

Authors:  Nobuhide Oshitani; Noriko Kamata; Ryuta Ooiso; Daichi Kawashima; Makoto Inagawa; Mitsue Sogawa; Masaki Iimuro; Yoshio Jinno; Kenji Watanabe; Kazuhide Higuchi; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

3.  High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial.

Authors:  Mitsuro Chiba; Tsuyotoshi Tsuji; Kunio Nakane; Satoko Tsuda; Hajime Ishii; Hideo Ohno; Yu Obara; Masafumi Komatsu; Haruhiko Tozawa
Journal:  Perm J       Date:  2020-11

4.  Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.

Authors:  Adérson Omar Mourão Cintra Damião; Matheus Freitas Cardoso de Azevedo; Alexandre de Sousa Carlos; Marcela Yumi Wada; Taciana Valéria Marcolino Silva; Flávio de Castro Feitosa
Journal:  World J Gastroenterol       Date:  2019-03-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.